Summary Oestrogen (ER) and progestin receptors (PR) were measured in cytosols from histologically normal mammary tissues (n=30), and in benign (n=59) and malignant mammary lesions (n=49) from female dogs. Receptor levels .5 fmol mg-1 protein were considered positive. The presence of histologically normal mammary epithelium within specimens of primary tumours was noticed as a factor that may cause falsepositive receptor results. Receptor levels in non-malignant tissues, and the receptor status of primary cancers did not vary significantly with regard to the phase of oestrous cycle (anoestrus/metoestrus) or the influence of exogenous progestins. ER-or PR-positivity was more frequent and levels of both receptors were higher in 'normal' tissues and in benign lesions than in primary cancers (P<0.001). ER and PR levels were higher in benign lesions of dogs also developing malignant mammary tumours than in benign lesions of dogs that did not (P<0.02 and P<0.05, respectively). Regional and distant cancer metastases were frequently receptornegative. In some dogs heterogeneity of receptor status was found between different sites of the same cancer.
Mammary cancer in the dog and in the human have several features in common, including the spontaneous occurrence and the sparing effect of ovariohysterectomy if performed early in life (Schneider et al., 1969 , Feinleib, 1968 . Oestrogen (ER) and progestin receptors (PR) have been found in a large proportion of mammary cancers in both species (Raynaud et al., 1981; McGuire et al., 1982; Pierrepoint et al., 1984) , indicating a role for sex steroid hormones in growth of such tumours. The receptor status of human breast cancer has become established as a useful predictor of the likelihood of response of the disease to endocrine therapy (McGuire et al., 1982) and has also been found to be related to the degree of differentiation (Fisher et al., 1987) . These observations may be interpreted as indications that steroid receptor presence in a tumour reflects persistence of normal cell characteristics. It has been difficult, however, to detect substantial amounts of ER in adult normal human breast tissue (Wagner & Jungblut, 1976) . This has led to the reverse view, namely, that expression of hormone receptors reflects a feature related to the process of neoplastic transformation (Israel & Band, 1984) .
The present study was undertaken in order to determine the ER and PR profile of histologically non-affected mammary glands and of benign and malignant (primary and/or metastatic) proliferative lesions in the dog. Results were related to histopathological and some clinical features of affected dogs. Results of a limited number of these determinations have been included in other reports Rutteman et al., , 1988 Those that were not used for ER/PR analysis were always examined histopathologically.
Tumour treatment consisted of surgery alone. Care was taken to document the simultaneous or sequential occurrence of mammary cancer in dogs presenting with benign lesions. After surgery for the latter, dogs were followed for at least 12 months (median 22, range 12-48 months) or until malignant disease was recognized. Clinical staging of dogs with cancer was done on the basis of the WIlO TNM classification for tumours in domestic animals (Owen, 1980) , where T stands for tumour condition, N for the condition of the regional lymph nodes and M for the absence/presence of distant metastasis (including distant nodes). Regional lymph nodes were considered involved only if tumour deposits were found at cytological or histological examination.
Reproductive cycle and progestin use The phase of the oestrus cycle was assessed by combining physical signs and determinations of plasma progesterone (P4) concentrations (Dieleman et al., 1979) 
Tissues
Upon surgery or autopsy -the latter always being completed within 30min following euthanasia -tissues were immediately placed in melting ice. Macroscopically tumorous and normal tissues, well separated from the former, were partly dissected, cleared of fat and necrotic parts and cut in blocks of + 0.5 cm diameter. Several blocks and the remaining specimen were fixed in 10% formalin for histopathological analysis and classification, according to WHO guidelines (Hampe & Misdorp, 1974) . The other blocks were frozen quickly in liquid nitrogen and stored at -70°C. Receptor analysis was performed within one month.
Analysis of non-affected mammary tissues (further referred to as normal tissues) has been confined to those that did not have areas of proliferative disorder at microscopic examination. The relative proportion of epithelial plus myoepithelial cells was assessed as percentage of tissue occupied in microscopic sections. Tumour specimens were analysed only if the proportion of viable tumour cells was .10%.
The group of benign proliferative lesions consisted of 11 lobular simple (epithelial) or complex (epithelial + myoepithelial) hyperplasias, 1 intraductal papilloma, 28 simple or complex adenomas, 6 fibroadenomas and 13 benign mixed tumours. The group of infiltrating cancers consisted of 7 simple tubular adenocarcinomas, 2 simple and 2 complex papillary adenocarcinomas, 19 simple and 3 complex solid carcinomas, 11 anaplastic carcinomas, 2 fibrosarcomas and 3 carcinosarcomas.
Histological grading of carcinomas and sarcomas was performed as described (Misdorp, 1976) .
Steroid receptor analysis ER and PR content and affinity were determined in the high speed cytosol of a sample by the multi-concentration dextran-coated charcoal method published previously with computation according to Scatchard (1949) . High affinity binding was considered present if the dissociation constant of the binding reaction (Kd) was <5lx10-1°M for ER and <5x 10-9M for PR. A value of .5fmolmg-1 cytosolic protein was taken as positive (ER+ and PR+, respectively). Lower values were considered negative (ER-and PR-, respectively).
At histological examination some samples of primary tumours were found to contain not only tumour but also histologically normal mammary epithelium, recognized on the basis of architectural features and lack of cellular atypia. Since normal mammary tissues frequently contain considerable ER and PR activity (Rutteman & Misdorp, 1986, and Results) , data on tumour specimens with normal mammary epithelium are considered liable to bias and therefore presented separately.
Data presentation and statistical analysis In studies where receptor status and levels were compared with other features recognized within tissue specimens, all specimens of a given diagnostic class of tissues were used. However, twelve dogs had 2 or 3 benign lesions assayed; on comparing receptor data with host factors or between different tissue classes, one specimen of this class was at random chosen to represent one animal. The Spearman rankcorrelation test was applied to test the correlation of two variables. The Wilcoxon rank-sum test was used for the analysis of differences between medians of data groups. The Fisher exact test for a dichotomy was used to test differences in frequency distribution in data groups. The level of significance was set at a P value of 0.05.
Results
Normal mammary gland tissues Normal mammary gland specimens (n = 30) were analysed in 30 intact female dogs, 3-12 years of age (median 94 years). Twenty-nine of these had positive ER and PR levels ( Table  I ). The ER and PR levels were proportional (Figure 1 ). No significant correlation was found between age and ER concentrations (r=0.21, P=NS), whereas a weak positive correlation was found between age and PR concentrations (r = 0.37, P <0.05). Epithelium content (%SA = percentage of surface area in microscopic sections occupied by epithelial plus myoepithelial cells) was not correlated with ER levels nor with PR levels (r=0.07 and -0.18, respectively). Specimens obtained in the phase of exogenous progestin influence as well as those in metoestrus had an increased epithelium content (%SA) as compared to those obtained in an oestrus, however, the latter difference was not significant (Figure 2 ). Levels of ER or of PR did not vary significantly between these three phases, although median values were highest in metoestrus (Figure 2 ). Dogs ever treated with injectable progestins did not have significantly different ER or PR levels from dogs never treated with such compounds (data not shown).
Benign proliferative lesions Fifty-nine benign proliferative lesions were examined in 45 dogs. Five of these had been spayed, the others were intact female dogs. The age ranged from 61-12 years (median 9 years).
In 6 benign lesions, all containing both ER and PR activity (Table I) , the presence of normal mammary epithelium was noticed. These data were considered to be susceptible to bias and were not further analysed. Forty-nine of the remaining 53 benign lesions (in 41 dogs) were ER + PR + (Table I) . Within the group of 'pure' benign lesions the ER and PR levels were proportional (Figure 1 ). Epithelium content (%SA) and ER levels were very weakly but significantly correlated (r=0.28, P<0.05), whereas the correlation of this factor with PR levels was not significant (r=0.22, P=NS).
Of dogs (n=10) with more than one benign lesion assayed, one specimen was chosen at random to represent that particular animal in comparisons of host factors with receptor data. These comparisons could thus be performed in 41 animals. No correlation was found between dog age (Figure 2 ). Neither was a significant variation established in ER or in PR levels among these phases, although median values were highest in metoestrus ( Figure 2) . The results from dogs in the phase of uncertain exogenous progestin influence (n = 4) and from spayed dogs (n=3) were too few in number to be considered in this comparison. Dogs ever treated with progestins (n = 13) did not have ER or PR concentrations significantly different from dogs that had never been treated (n=28, data not shown).
The development of malignant mammary tumours before, simultaneously with, or after operation upon benign lesions was established in 14 dogs, whereas 24 dogs remained free from signs of mammary cancer. Three animals were lost at follow-up. Concentrations of both receptors were found to be higher in benign lesions of dogs also developing mammary cancer (ER, median 71, range 26-123 fmol mg-1 protein; PR, median 136, range 25-546fmolmg-1 protein) than of those that did not (ER, median 39, range 0-lOOfmolmg-1 protein, P<0.02; PR, median 65, range 0-371 fmol mg-1 protein, P < 0.05). Median epithelium content was equal in both groups.
ER levels in the 'pure' benign lesions were similar to those in normal tissues, whereas PR levels were distinctly higher in the former (Table I ). This result was found both when this comparison was performed with the complete group of benign lesions as well as with the reduced group in which one specimen was chosen at random per animal (difference in PR levels for both conditions, P<0.02).
Malignant tumours This group consisted of 49 tumours in 47 dogs. Receptor assays were performed in 44 primary growths of 42 dogs; two dogs had bilateral cancers. In 5 dogs the primary tumour was not available for receptor assay: in these cases metastatic sites only (n=3) or combined with locally recurrent lesions (n=2) were examined.
In 3 primary cancers malignant areas were found together with histologically benign tumour structures. In another 18 primary cancers the presence of normal mammary epithelium was noticed. Receptor results of these, mainly ER+PR+, 'non-pure' tumours were considered susceptible to bias. Indeed, a positive status for ER as well as for PR was more frequent in 'non-pure' primary cancers and levels of both receptors were higher than in 'pure' cancer specimens (Table I) .
The 23 'pure' primary cancers (23 dogs) were studied in more detail. The age at first presentation ranged from 5-13 years (median 9 years). Three of the dogs had been spayed, the others were intact female dogs. ER and PR-positivity was less frequent and the levels were lower than in normal mammary tissues or in 'pure' benign lesions (Table I) (Hamilton et al., 1977;  and ER (r=0.17) or PR level Elling & Ungemach, 1983) . ER-and PR-positivity has also (ses in this group were confined to been demonstrated in mammary tissue of normal dogs ical assessment of the relation of (d'Arville, 1979; Bergink et al., 1980) . ER and PR levels (ogenous progestin influence with given in these latter reports, as well as those found by us in ted, since the number of cases in 5 two-year-old normal beagle bitches (unpublished results) )o low. However, no pattern of were in the same range as those determined in the present apparent (data not shown).
series. Thus, it is not likely that the level of expression of ER The increased epithelium content during progestin treatvere found in 2 of 3 dogs with ment or in metoestrus compared to that in anoestrus may Ivement and in 10 (ER) and 9 (PR) reflect the high proliferative activity of glandular epithelium involvement respectively. However, that is known to occur in the dog during progestin exposure ogs with stage IV (M1) disease a (Bergink et al., 1984; Spanel-Borowski et al., 1984) . In f PR (5/6) was somewhat more contrast, no such increase was observed in benign lesions. In of dogs with stage 1-111 disease addition, ER or PR levels in normal tissues or in benign -: 8/17, P = 0.14).
lesions did not vary significantly with regard to anoestrus or n in ER or PR status was seen metoestrus or period of exogenous progestin influence. In ,ical malignancy grades or nuclear dog uterus, ER and PR levels have been found to rise several-fold during the period of follicular oestrogen secretion above values in anoestrus. In metoestrus a decrease occurs to values slightly below those in anoestrus (Johnston ) (Allegra et al., 1979; Brentani et al., 1986 did not, may indicate an enhancement in the phenotypic expression of hormone receptors in tissues engaged in the process of malignant transformation (Cikes, 1978 . In the human, steroid receptor positivity of cancer metastases is more common, and receptor levels both in primary cancers as well as in metastases are often higher (Vihko et al., 1980; Wittliff, 1984) , than in our series of dog cancers. This may indicate that in the dog, a loss of hormone dependency occurs at an earlier stage than in man. Yet, loss of ER or PR may also occur in human breast cancer (not treated with endocrine measures) at progression of the disease towards overt metastasis (Osborne, 1983) . Furthermore, in primary human breast cancer, the presence of steroid receptors is positively correlated with state of differentiation (Fisher et al., 1987) . Thus, more malignant conditions may be more often steroid receptor-negative in both species.
In conclusion, unaltered mammary tissues and benign lesions in the dog frequently contain both ER and PR. This feature is less common in primary cancers and infrequent in distant metastases. This indicates a change from steroid hormone dependency towards independency with dedifferentiation and progression of mammary tumour disease. Increased production of growth factors and/or growth factors receptors may be one of the mechanisms by which tumour cells overcome steroid hormone dependency (Dickson & Lippman, 1986) .
